Board trying to lower drug costs urges Marylanders to help ‘fill in’ info gaps

Before a state board can begin the process of determining if certain prescription drugs pose an affordability challenge to Marylanders, officials of the Prescription Drug Affordability Board are seeking feedback from patients, physicians and manufactures to provide additional context and first-hand experience about trying to afford medications treating HIV, eczema, and diabetes and other conditions.